News stories about Cooper Companies, Inc. (The) (NYSE:COO) have trended somewhat positive this week, Accern Sentiment reports. Accern rates the sentiment of media coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Cooper Companies, Inc. (The) earned a media sentiment score of 0.05 on Accern’s scale. Accern also assigned news articles about the medical device company an impact score of 42 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

These are some of the media stories that may have effected Accern Sentiment Analysis’s analysis:

COO has been the subject of a number of recent analyst reports. Piper Jaffray Companies reissued an “overweight” rating and set a $220.00 price objective on shares of Cooper Companies, Inc. (The) in a research report on Thursday, April 6th. Zacks Investment Research raised Cooper Companies, Inc. (The) from a “hold” rating to a “buy” rating and set a $226.00 price objective for the company in a research report on Wednesday, May 3rd. Stifel Nicolaus raised their price objective on Cooper Companies, Inc. (The) from $220.00 to $231.00 and gave the stock a “buy” rating in a research report on Friday, June 2nd. Jefferies Group LLC reissued a “buy” rating and set a $250.00 price objective (up from $220.00) on shares of Cooper Companies, Inc. (The) in a research report on Saturday, June 3rd. Finally, Oppenheimer Holdings, Inc. set a $225.00 price objective on Cooper Companies, Inc. (The) and gave the stock a “hold” rating in a research report on Saturday, June 3rd. Three investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $237.00.

Cooper Companies, Inc. (COO) traded up 1.59% during trading on Friday, reaching $250.36. The company’s stock had a trading volume of 549,153 shares. The company has a market capitalization of $12.23 billion, a P/E ratio of 37.54 and a beta of 0.61. Cooper Companies, Inc. has a 1-year low of $158.73 and a 1-year high of $252.05. The company’s 50-day moving average is $229.73 and its 200-day moving average is $200.61.

Cooper Companies, Inc. (The) (NYSE:COO) last released its quarterly earnings data on Thursday, June 1st. The medical device company reported $2.50 EPS for the quarter, topping analysts’ consensus estimates of $2.25 by $0.25. The company had revenue of $522.40 million for the quarter, compared to the consensus estimate of $520.71 million. Cooper Companies, Inc. (The) had a return on equity of 15.88% and a net margin of 16.02%. The company’s quarterly revenue was up 8.0% compared to the same quarter last year. During the same period last year, the business posted $2.05 EPS. Equities analysts anticipate that Cooper Companies, Inc. will post $9.61 EPS for the current year.

The company also recently disclosed a semiannual dividend, which will be paid on Monday, August 7th. Stockholders of record on Friday, July 21st will be issued a $0.03 dividend. The ex-dividend date is Wednesday, July 19th. This represents a dividend yield of 0.02%. Cooper Companies, Inc. (The)’s dividend payout ratio (DPR) is 0.90%.

In other news, CEO Paul L. Remmell sold 9,294 shares of the stock in a transaction dated Friday, July 14th. The stock was sold at an average price of $248.46, for a total value of $2,309,187.24. Following the completion of the sale, the chief executive officer now owns 6,186 shares in the company, valued at $1,536,973.56. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, VP Randal Golden sold 1,621 shares of the stock in a transaction dated Tuesday, July 11th. The shares were sold at an average price of $243.65, for a total value of $394,956.65. Following the completion of the sale, the vice president now owns 1,731 shares of the company’s stock, valued at approximately $421,758.15. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 67,331 shares of company stock worth $16,400,454. Company insiders own 1.60% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This news story was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this news story on another website, it was copied illegally and republished in violation of US and international copyright and trademark legislation. The correct version of this news story can be viewed at https://www.thecerbatgem.com/2017/07/16/somewhat-positive-news-coverage-somewhat-unlikely-to-impact-cooper-companies-inc-the-coo-stock-price.html.

Cooper Companies, Inc. (The) Company Profile

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Insider Buying and Selling by Quarter for Cooper Companies, Inc. (The) (NYSE:COO)

Receive News & Stock Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related stocks with our FREE daily email newsletter.